A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
Completed · Phase 3 · Has a placebo group
Conditions studied: Eosinophilic Gastritis, Eosinophilic Duodenitis
In brief
This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002), given monthly for 6 doses, in patients with moderately to severely active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) who have an inadequate response with, lost response to, or were intolerant to standard therapies
Key facts
- Study ID
- NCT04322604
- Run by
- Allakos Inc.
- People needed
- 181
- Starts
- 2020-06-18
- Expected to finish
- 2022-01-12
- Last updated by the study team
- 2024-01-02
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Allakos Investigational Site — Huntsville, Alabama, United States
- Allakos Investigational Site — Gilbert, Arizona, United States
- Allakos Investigational Site — Phoenix, Arizona, United States
- Allakos Investigational Site — Scottsdale, Arizona, United States
- Allakos Investigational Site — Little Rock, Arkansas, United States
- Allakos Investigational Site — Chula Vista, California, United States
- Allakos Investigational Site — La Jolla, California, United States
- Allakos Investigational Site — Murrieta, California, United States
- Allakos Investigational Site — Oakland, California, United States
- Allakos Investigational Site — Santa Monica, California, United States
- Allakos Investigational Site — Tustin, California, United States
- Allakos Investigational Site — Ventura, California, United States
- Allakos Investigational Site — Walnut Creek, California, United States
- Allakos Investigational Site — Aurora, Colorado, United States
- Allakos Investigational Site — Colorado Springs, Colorado, United States
- Allakos Investigational Site — Bristol, Connecticut, United States
- Allakos Investigational Site — Brandon, Florida, United States
- Allakos Investigational Site — Edgewater, Florida, United States
- Allakos Investigational Site — Jacksonville, Florida, United States
- Allakos Investigational Site — Miami, Florida, United States
- Allakos Investigational Site — New Port Richey, Florida, United States
- Allakos Investigational Site — Atlanta, Georgia, United States
- Allakos Investigational Site — Chicago, Illinois, United States
- Allakos Investigational Site — Crowley, Louisiana, United States
- Allakos Investigational Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.